BackCalithera Biosciences Overview

Calithera Biosciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CALA.

Quarterly EBIT

-$7.35M
↑ 89.39% YoY

As of Dec 31, 2022

Annual EBIT (TTM)

-$42.07M
↑ 63.55% YoY

Trailing 12 months ending Dec 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin